Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.
Endometrial carcinoma is one of the most common gynecologic malignancies in Japan and its incidence has increased recently. Although surgery is the cornerstone of the management of patients with endometrial cancer, there is significant variation in Japan with regard to the type of hysterectomy employed. Additionally, it remains controversial whether full nodal staging is required in all patients. Furthermore, adjuvant therapy differs between Japan and Western countries. To delineate clearly the standard of care for endometrial cancer treatment in Japan, the guidelines for the treatment of endometrial cancer were published in 2006 and revised in 2009. The 2009 edition included topics not addressed in the previous edition including the treatment of mesenchymal tumors, for example leiomyosarcoma, and sections covering the treatment of serous and clear-cell adenocarcinoma. These guidelines are composed of nine chapters and include nine algorithms. The guidelines also contain fifty-one clinical questions (CQs) and each CQ consists of recommendations, background, explanations, and references. The treatment recommendations herein are tailored to reflect current Japanese clinical practice and ensure equitable care for all Japanese women diagnosed with endometrial cancer.
Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. nagases@med.tohoku.ac.jp
Satoru
S
Nagase
Hidetaka
H
Katabuchi
Masamichi
M
Hiura
Noriaki
N
Sakuragi
Yoichi
Y
Aoki
Junzo
J
Kigawa
Tsuyoshi
T
Saito
Toru
T
Hachisuga
Kiyoshi
K
Ito
Takashi
T
Uno
Noriyuki
N
Katsumata
Shinichi
S
Komiyama
Nobuyuki
N
Susumu
Makoto
M
Emoto
Hiroaki
H
Kobayashi
Hirohito
H
Metoki
Ikuo
I
Konishi
Kazunori
K
Ochiai
Mikio
M
Mikami
Toru
T
Sugiyama
Makio
M
Mukai
Satoru
S
Sagae
Hiroshi
H
Hoshiai
Daisuke
D
Aoki
Masahide
M
Ohmichi
Hiroyuki
H
Yoshikawa
Tsuyoshi
T
Iwasaka
Yasuhiro
Y
Udagawa
Nobuo
N
Yaegashi
D018262:Adenocarcinoma, Clear Cell / Q000628:therapy*; D003131:Combined Modality Therapy; D016889:Endometrial Neoplasms / Q000628:therapy*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007564:Japan; D008495:Medical Oncology; D059039:Standard of Care; D014594:Uterine Neoplasms / Q000628:therapy*